Advocates in Massachusetts look to reverse recreational marijuana legalization By HPN staff Key Points Massachusetts advocates submitted ~76,000 signatures to advance a proposal banning recreational marijuana, potentially setting up a 2026 ballot question that would ... Read more The biosecurity crossroads: Decline or dominance By Matthew McKnight Key Points The testimony argues that future global leadership will hinge on control of biology and bio-manufacturing, warning that failure to invest could leave the U.S... Read more Artificial intelligence and the future of biodefense readiness By Jassi Pannu Key Points While AI is advancing rapidly in commercial biology and medicine, biosecurity and biodefense applications remain under-incentivized by the private sector, requiri... Read more Spurring innovation in the biotech industry will save lives By John Crowley Key Points Crowley emphasized that maintaining U.S. leadership in biotechnology is vital to both public health and national security, especially amid China’s rapid rise in ... Read more AI use exploding in healthcare industry, as providers gain confidence in its use By HPN Staff Key Points Physician use of AI in healthcare jumped from 38% in 2023 to 66% in 2024, reflecting growing trust and reliance on the technology. AI is now used for dia... Read more AI’s potential to deliver better patient care By Russ Altman Key Points Over 75% of FDA-cleared AI tools are for medical imaging, but emerging systems now integrate patient data, notes, and genetics to predict disease risks and guide ... Read more Democrats push single-payer healthcare at state level By HPN Staff Key Points With little progress federally, Democrats and advocacy groups are turning to state governments to test and implement single-payer models. The proposed St... Read more FDA’s top vaccine official returns to post after controversial resignation By HPN Staff Key Points Dr. Vinay Prasad resigned as head of the FDA’s Center for Biologics Evaluation and Research (CBER) after controversy over halting Sarepta’s g... Read more Subscribe to Massachusetts MOST VIEWED 1 GAO says ACA fraud is rampant 2 States to receive an average of $200M for rural healthcare 3 U.S. nutrition guidelines shift back toward a pyramid — but with a twist 4 Advocates in Massachusetts look to reverse recreational marijuana legalization DONATE
The biosecurity crossroads: Decline or dominance By Matthew McKnight Key Points The testimony argues that future global leadership will hinge on control of biology and bio-manufacturing, warning that failure to invest could leave the U.S... Read more Artificial intelligence and the future of biodefense readiness By Jassi Pannu Key Points While AI is advancing rapidly in commercial biology and medicine, biosecurity and biodefense applications remain under-incentivized by the private sector, requiri... Read more Spurring innovation in the biotech industry will save lives By John Crowley Key Points Crowley emphasized that maintaining U.S. leadership in biotechnology is vital to both public health and national security, especially amid China’s rapid rise in ... Read more AI use exploding in healthcare industry, as providers gain confidence in its use By HPN Staff Key Points Physician use of AI in healthcare jumped from 38% in 2023 to 66% in 2024, reflecting growing trust and reliance on the technology. AI is now used for dia... Read more AI’s potential to deliver better patient care By Russ Altman Key Points Over 75% of FDA-cleared AI tools are for medical imaging, but emerging systems now integrate patient data, notes, and genetics to predict disease risks and guide ... Read more Democrats push single-payer healthcare at state level By HPN Staff Key Points With little progress federally, Democrats and advocacy groups are turning to state governments to test and implement single-payer models. The proposed St... Read more FDA’s top vaccine official returns to post after controversial resignation By HPN Staff Key Points Dr. Vinay Prasad resigned as head of the FDA’s Center for Biologics Evaluation and Research (CBER) after controversy over halting Sarepta’s g... Read more Subscribe to Massachusetts
Artificial intelligence and the future of biodefense readiness By Jassi Pannu Key Points While AI is advancing rapidly in commercial biology and medicine, biosecurity and biodefense applications remain under-incentivized by the private sector, requiri... Read more Spurring innovation in the biotech industry will save lives By John Crowley Key Points Crowley emphasized that maintaining U.S. leadership in biotechnology is vital to both public health and national security, especially amid China’s rapid rise in ... Read more AI use exploding in healthcare industry, as providers gain confidence in its use By HPN Staff Key Points Physician use of AI in healthcare jumped from 38% in 2023 to 66% in 2024, reflecting growing trust and reliance on the technology. AI is now used for dia... Read more AI’s potential to deliver better patient care By Russ Altman Key Points Over 75% of FDA-cleared AI tools are for medical imaging, but emerging systems now integrate patient data, notes, and genetics to predict disease risks and guide ... Read more Democrats push single-payer healthcare at state level By HPN Staff Key Points With little progress federally, Democrats and advocacy groups are turning to state governments to test and implement single-payer models. The proposed St... Read more FDA’s top vaccine official returns to post after controversial resignation By HPN Staff Key Points Dr. Vinay Prasad resigned as head of the FDA’s Center for Biologics Evaluation and Research (CBER) after controversy over halting Sarepta’s g... Read more Subscribe to Massachusetts
Spurring innovation in the biotech industry will save lives By John Crowley Key Points Crowley emphasized that maintaining U.S. leadership in biotechnology is vital to both public health and national security, especially amid China’s rapid rise in ... Read more AI use exploding in healthcare industry, as providers gain confidence in its use By HPN Staff Key Points Physician use of AI in healthcare jumped from 38% in 2023 to 66% in 2024, reflecting growing trust and reliance on the technology. AI is now used for dia... Read more AI’s potential to deliver better patient care By Russ Altman Key Points Over 75% of FDA-cleared AI tools are for medical imaging, but emerging systems now integrate patient data, notes, and genetics to predict disease risks and guide ... Read more Democrats push single-payer healthcare at state level By HPN Staff Key Points With little progress federally, Democrats and advocacy groups are turning to state governments to test and implement single-payer models. The proposed St... Read more FDA’s top vaccine official returns to post after controversial resignation By HPN Staff Key Points Dr. Vinay Prasad resigned as head of the FDA’s Center for Biologics Evaluation and Research (CBER) after controversy over halting Sarepta’s g... Read more Subscribe to Massachusetts
AI use exploding in healthcare industry, as providers gain confidence in its use By HPN Staff Key Points Physician use of AI in healthcare jumped from 38% in 2023 to 66% in 2024, reflecting growing trust and reliance on the technology. AI is now used for dia... Read more AI’s potential to deliver better patient care By Russ Altman Key Points Over 75% of FDA-cleared AI tools are for medical imaging, but emerging systems now integrate patient data, notes, and genetics to predict disease risks and guide ... Read more Democrats push single-payer healthcare at state level By HPN Staff Key Points With little progress federally, Democrats and advocacy groups are turning to state governments to test and implement single-payer models. The proposed St... Read more FDA’s top vaccine official returns to post after controversial resignation By HPN Staff Key Points Dr. Vinay Prasad resigned as head of the FDA’s Center for Biologics Evaluation and Research (CBER) after controversy over halting Sarepta’s g... Read more Subscribe to Massachusetts
AI’s potential to deliver better patient care By Russ Altman Key Points Over 75% of FDA-cleared AI tools are for medical imaging, but emerging systems now integrate patient data, notes, and genetics to predict disease risks and guide ... Read more Democrats push single-payer healthcare at state level By HPN Staff Key Points With little progress federally, Democrats and advocacy groups are turning to state governments to test and implement single-payer models. The proposed St... Read more FDA’s top vaccine official returns to post after controversial resignation By HPN Staff Key Points Dr. Vinay Prasad resigned as head of the FDA’s Center for Biologics Evaluation and Research (CBER) after controversy over halting Sarepta’s g... Read more Subscribe to Massachusetts
Democrats push single-payer healthcare at state level By HPN Staff Key Points With little progress federally, Democrats and advocacy groups are turning to state governments to test and implement single-payer models. The proposed St... Read more FDA’s top vaccine official returns to post after controversial resignation By HPN Staff Key Points Dr. Vinay Prasad resigned as head of the FDA’s Center for Biologics Evaluation and Research (CBER) after controversy over halting Sarepta’s g... Read more Subscribe to Massachusetts
FDA’s top vaccine official returns to post after controversial resignation By HPN Staff Key Points Dr. Vinay Prasad resigned as head of the FDA’s Center for Biologics Evaluation and Research (CBER) after controversy over halting Sarepta’s g... Read more Subscribe to Massachusetts
